Alpha 2.0

» Articles » PMID: 33693175

5-Aminolevulinic Acid Attenuates Atherosclerotic Plaque Progression in Low-Density Lipoprotein Receptor-Deficient Mice by Heme Oxygenase-1 Induction

Overview

Overview

Journal Circ Rep

Date 2021 Mar 11

PMID 33693175

Citations 2

Authors

Authors

Kohsuke Hagisawa

Makoto Ayaori

Katsunori Ikewaki

Motowo Nakajima

Yuji Morimoto

Affiliations

Affiliations

Soon will be listed here.

Abstract

Recently, 5-aminolevulinic acid (ALA) has been reported to modulate inflammatory development via an antioxidant effect. Hence, the aim of this study was to determine the anti-atherosclerotic effect of ALA. Low-density lipoprotein (LDL) receptor knockout mice were fed the following diets for 24 weeks: normal diet (n=6); 1.25% cholesterol diet (high-cholesterol diet, HCD; n=7); HCD+ALA (46 mg/kg/day; n=10); and HCD+ezetimibe (5 mg/kg/day; n=10). At 40 weeks, HCD+ALA had reduced LDL cholesterol (320±68 vs. 379±49 mg/dL), triglyceride (141±44 vs. 195±49 mg/dL) and oxidized LDL (380±40 vs. 422±64 pg/mL) compared with HCD only. En face lesion area for the entire aortic surface was significantly smaller in mice that received HCD+ALA than in mice that received only HCD (32±5% vs. 39±4%, P<0.05). ALA intake exogenously increased tissue heme oxygenase-1 (HO-1) level in plaque composite tissue of the carotid arterial wall compared with HCD only (18±8 vs. 12±3 pg/μL, P<0.05), and HO-1-positive plaque showed modest NADPH oxidase 4 expression. ALA intake induces exogenous production of HO-1 at plaque sites, and improves lipid profiles and attenuation of atherosclerotic plaque progression in vivo.

Citing Articles

Therapeutic potential of 5-aminolevulinic acid in metabolic disorders: Current insights and future directions.

Kuryata O, Akimov O, Riabushko M, Kostenko H, Kostenko V, Mishchenko A iScience. 2024; 27(12):111477.

PMID: 39720526 PMC: 11667047. DOI: 10.1016/j.isci.2024.111477.

Recent Developments in Protein Lactylation in PTSD and CVD: Novel Strategies and Targets.

Kozlakidis Z, Shi P, Abarbanel G, Klein C, Sfera A BioTech (Basel). 2023; 12(2).

PMID: 37218755 PMC: 10204439. DOI: 10.3390/biotech12020038.

References

1.

Forstermann U . Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med. 2008; 5(6):338-49. DOI: 10.1038/ncpcardio1211. View

2.

An Y, Liu L, Chen L, Wang L . ALA Inhibits ABA-induced Stomatal Closure via Reducing H2O2 and Ca(2+) Levels in Guard Cells. Front Plant Sci. 2016; 7:482. PMC: 4826879. DOI: 10.3389/fpls.2016.00482. View

3.

Nishio Y, Fujino M, Zhao M, Ishii T, Ishizuka M, Ito H . 5-Aminolevulinic acid combined with ferrous iron enhances the expression of heme oxygenase-1. Int Immunopharmacol. 2014; 19(2):300-7. DOI: 10.1016/j.intimp.2014.02.003. View

4.

Maruhashi K, Kasahara Y, Ohta K, Wada T, Ohta K, Nakamura N . Paradoxical enhancement of oxidative cell injury by overexpression of heme oxygenase-1 in an anchorage-dependent cell ECV304. J Cell Biochem. 2004; 93(3):552-62. DOI: 10.1002/jcb.20170. View

5.

LAbbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, Baldi S . Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am J Physiol Heart Circ Physiol. 2007; 293(6):H3532-41. DOI: 10.1152/ajpheart.00826.2007. View

6.

Salazar G . NADPH Oxidases and Mitochondria in Vascular Senescence. Int J Mol Sci. 2018; 19(5). PMC: 5983750. DOI: 10.3390/ijms19051327. View

7.

Harrison D, Griendling K, Landmesser U, Hornig B, Drexler H . Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003; 91(3A):7A-11A. DOI: 10.1016/s0002-9149(02)03144-2. View

8.

Stocker R, Keaney Jr J . Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004; 84(4):1381-478. DOI: 10.1152/physrev.00047.2003. View

9.

Vendrov A, Vendrov K, Smith A, Yuan J, Sumida A, Robidoux J . NOX4 NADPH Oxidase-Dependent Mitochondrial Oxidative Stress in Aging-Associated Cardiovascular Disease. Antioxid Redox Signal. 2015; 23(18):1389-409. PMC: 4692134. DOI: 10.1089/ars.2014.6221. View

10.

Mikhed Y, Daiber A, Steven S . Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction. Int J Mol Sci. 2015; 16(7):15918-53. PMC: 4519931. DOI: 10.3390/ijms160715918. View

11.

Umemoto T, Subramanian S, Ding Y, Goodspeed L, Wang S, Han C . Inhibition of intestinal cholesterol absorption decreases atherosclerosis but not adipose tissue inflammation. J Lipid Res. 2012; 53(11):2380-9. PMC: 3466006. DOI: 10.1194/jlr.M029264. View

12.

Li H, Forstermann U . Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease. Curr Opin Pharmacol. 2013; 13(2):161-7. DOI: 10.1016/j.coph.2013.01.006. View

13.

Koganei M, Saitou Y, Tsuchiya K, Abe F, Tanaka T, Horinouchi I . Effects of 5-aminolevulinic acid on a murine model of diet-induced obesity. J Clin Biochem Nutr. 2015; 57(2):145-50. PMC: 4566019. DOI: 10.3164/jcbn.13-58. View

14.

Datla S, Dusting G, Mori T, Taylor C, Croft K, Jiang F . Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension. 2007; 50(4):636-42. DOI: 10.1161/HYPERTENSIONAHA.107.092296. View

15.

Ota U, Hara T, Nakagawa H, Tsuru E, Tsuda M, Kamiya A . 5-aminolevulinic acid combined with ferrous ion reduces adiposity and improves glucose tolerance in diet-induced obese mice via enhancing mitochondrial function. BMC Pharmacol Toxicol. 2017; 18(1):7. PMC: 5278573. DOI: 10.1186/s40360-016-0108-3. View

16.

Lozhkin A, Vendrov A, Pan H, Wickline S, Madamanchi N, Runge M . NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis. J Mol Cell Cardiol. 2016; 102:10-21. PMC: 5625334. DOI: 10.1016/j.yjmcc.2016.12.004. View

17.

Sato T, Yasuzawa T, Uesaka A, Izumi Y, Kamiya A, Tsuchiya K . Type 2 diabetic conditions in Otsuka Long-Evans Tokushima Fatty rats are ameliorated by 5-aminolevulinic acid. Nutr Res. 2014; 34(6):544-51. DOI: 10.1016/j.nutres.2014.04.013. View

18.

Abraham N, Kappas A . Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 2008; 60(1):79-127. DOI: 10.1124/pr.107.07104. View

19.

Siti H, Kamisah Y, Kamsiah J . The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascul Pharmacol. 2015; 71:40-56. DOI: 10.1016/j.vph.2015.03.005. View

20.

Li M, Kim D, Tsenovoy P, Peterson S, Rezzani R, Rodella L . Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes. 2008; 57(6):1526-35. DOI: 10.2337/db07-1764. View